Abstract:Background: The number of patients with end-stage renal disease and acute kidney injury in China is large and increasing year by year. Continuous renal replacement therapy (CRRT) is one of the important treatment methods. However, long-time CRRT would inevitably lead to CLABSI, which would seriously affect the treatment and prognosis of the patient. Although CLABSIs can be prevented and controlled, the rate of CLABSI in China is still higher than in other countries. Therefore, it is urgent to find new intervention methods on the basis of existing methods. Surveillance is the prerequisite of infection prevention and control. We sought to develop a risk prediction model for CLABSI in patients with CRRT according to uncontrollable risk factors, which could be used for early assessment and screening of high-risk infection groups. Such a tool would bring the supervision and infection control to the forefront in addressing these issues. Methods: We selected 3,103 CRRT patients in the West China Hospital of Sichuan University from January 2013 to December 2018 using the hospital infection and infectious disease monitoring module of electronic medical records (EMR) system with the integration and elimination criteria. Data mining and feature selection were performed using Weka software. Separately, prediction models developed by Weka software and SPSS software were compared with each other using the area under the curve (AUC) method to assess the performance of the forecasting models. Result: The incidence of CLABSI in CRRT patients was 8.01 per 1,000 catheter days (238 of 29,711). According to the multifactor regression analysis by SPSS software, the retaining time of dialysis catheter, C-reactive protein levels, total bilirubin, acute pancreatitis, and systemic inflammation reaction syndrome were the risk factors. According to the Youden’s index, the cutoff point of the retaining time of dialysis catheter was 5.5 days; the cutoff point of CRP was 112.5mg/L; and the cutoff point of total bilirubin was 14.15 μmol/L. The prediction models of CLABSI for CRRT patients were developed: The AUC of the prediction model developed by SPSS software was 0.763 (95% CI, 0.717–0.809). The receiver operating characteristic (ROC) curve analysis showed that the AUCs of the prediction models developed separately by Weka software using Bayes, logistic regression analysis, multiple layer Perceptron and J48, and SPSS software through logistic regression analysis were between 0.6 and 0.8. Using the down-sampling technique, the AUC ranged between 0.7 and 0.9, and the sensitivity, precision, and κ value increased. Thus, these models had definite clinical significance. Conclusion: The prediction models of CLABSI for CRRT patients, developed based on the big healthcare data, not only had good judgment ability, but also had good application value for individual evaluations and the target population. Funding: This study was supported by the Health Commission of Sichuan Province. Disclosures: None

Development and internal validation of a model for predicting cefoperazone/sulbactam-associated coagulation disorders in Chinese inpatients

Cardiovascular Disease Risk Prediction Models in Chinese Population- A Systematic Review and Meta-Analysis

Development and Validation of the UCSS Score, a Novel Method to Predict Septic Shock after PCNL

Development and Validation of Risk Prediction Model for Identifying 30-Day Frailty in Older Inpatients with Undernutrition: A Multicenter Cohort Study.

Feasibility of developing HAP risk warning model in critically ill patients based on genomic copy number polymorphisms of DEFA1/DEFA3

Development and Validation of Prognostic Models for Bleeding and Ischemia in Elderly Patients With Comorbid Acute Coronary Syndrome and Atrial Fibrillation

A Multifactor Model for Predicting Mortality in Critically Ill Patients: A Multicenter Prospective Cohort Study

Predicting hypovitaminosis C with LASSO algorithm in adult critically ill patients in surgical intensive care units: a bi-center prospective cohort study

Establishment and validation of a risk prediction model incorporating concentrations of linezolid and its metabolite PNU142300 for linezolid-induced thrombocytopenia

Development and validation of a postoperative bleeding complications prediction model in infective endocarditis

Development and validation of a predictive model for new-onset atrial fibrillation in sepsis based on clinical risk factors

A machine-learning approach for dynamic prediction of sepsis-induced coagulopathy in critically ill patients with sepsis: an integrated analysis of the MIMIC-IV and eICU-CRD databases

Development and Validation of Predictive Model—HASBLAD Score—For Major Adverse Cardiovascular Events During Perioperative Period of Non-cardiac Surgery: A Single Center Experience in China

Development and Validation of a New Clinical Prediction Model of Catheter-Related Thrombosis in Cancer Patients.

A new score for predicting intracranial hemorrhage in patients using antiplatelet drugs

A Predictive Model Based on Blood Indicators for Admission to the ICU with AECOPD

Physiologically Based Pharmacokinetic Model of Renally Cleared Antibacterial Drugs in Chinese Renal Impairment Patients.

Development and Validation of a Risk Prediction Model for In-Hospital Mortality in Patients With Acute Upper Gastrointestinal Bleeding

Machine Learning Models Predict Coagulopathy in Spontaneous Intracerebral Hemorrhage Patients in ER

Development of a Risk Prediction Model for Central-Line–Associated Bloodstream Infection (CLABSI) in Patients With Continuous Renal Replacement Therapy

Development of a model for predicting acute cerebral infarction induced by non-variceal upper gastrointestinal bleeding